Skip to main content

Table 4 Pre and post data, mean (SD) unless otherwise specified

From: Feasibility and adherence to moderate intensity cardiovascular fitness training following stroke: a pilot randomized controlled trial

  Baseline Intervention (n = 10) Follow-up intervention MD (95% CI)
(n = 10a)
P Baseline control (n = 10) Follow-up control MD (95% CI)
(n = 9)
P
VO2 peak 17.5 (2.9) 20.1 (4.9) 2.6 (0.5, 4.6) 0.02* 14.4 (3.7) 17.4 (4.4) 3.0 (1.0, 5.0) 0.01*
6MWT 400.9 (111.6) 443.4 (126.4) 42.5 (−10.9, 95.9) 0.11 344.8 (150.6) 370.9 (126.0) 26.1 (−15.3, 67.5) 0.18
10MWT Self 1.16 (0.29) 1.20 (0.21) 0.04 (−0.11, 0.20) 0.53 0.95 (0.38) 0.97 (0.36) 0.02 (−0.13, 0.17) 0.74
10MWT Fast 1.47 (0.36) 1.57 (0.41) 0.10 (−0.13, 0.32) 0.35 1.20 (0.47) 1.31 (0.52) 0.10 (−0.04, 0.25) 0.13
SF-36 PCSb 43.12 (8.65) 45.78 (8.97) 2.67 (−2.7, 8.0) 0.28 37.92 (10.16) 40.43 (9.90) 2.51 (−6.1, 11.1) 0.52
SF-36 MCSb 42.63 (14.72) 48.48 (17.65) 5.85 (−1.9, 13.6) 0.12 34.68 (20.35) 46.19 (10.50) 11.51 (0.09, 22.9) 0.049*
PHQ-9 7.0 (7.1) 4.2 (7.1) −2.8 (−8.1, 2.5) 0.26 8.1 (6.2) 3.8 (3.6) −4.3 (−6.6, −2.0) 0.003*
  1. CI Confidence interval. p values are calculated using paired samples t-tests with the exception of the 10MWT analyses which were performed using the Wilcoxon-signed ranks test. VO2 = ml/kg/min; 6MWT Six minute walk test (metres), 10MWT 10 m walk test, SF-36 Short Form 36, PCS Physical Component Summary Score, MCS Mental Component Summary Score, PHQ-9 Patient Health Questionnaire
  2. One participant in the control group was lost to follow-up
  3. *p < 0.05. aExcept for VO2 peak where n = 9. bn = 8 (Intervention), n = 9 (Control)